According to Prof. Cunningham, following the direction of a simple, rapid, and inexpensive assay that can be frequently performed to enable early detection, treatment planning, effectiveness measurement, and recurrence monitoring, scientists developed a non-invasive point-of-care device for routine use in clinical settings. The device, which can be used at room temperature, recently highlighted the ability to detect mutated molecules directly out of human serum and quickly give precise results after only one minute with one testing step.